INT314710

From wiki-pain
Revision as of 18:52, 24 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.00
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (ZNF639) intracellular (ZNF639) DNA binding (ZNF639)
ZNF639 (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 5 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Carcinoma 7 100.00 Very High Very High Very High
Breast Cancer 123 98.18 Very High Very High Very High
Advanced Or Metastatic Breast Cancer 4 94.96 High High
Cancer 91 86.44 High High
Disease Progression 1 78.48 Quite High
Death 4 60.56 Quite High
Disease 16 5.00 Very Low Very Low Very Low
Metastasis 10 5.00 Very Low Very Low Very Low
Recurrence 9 5.00 Very Low Very Low Very Low
Malignant Neoplastic Disease 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The humanized monoclonal antibody, trastuzumab (Herceptin®, Genentech, CA) is used for treatment of HER2-positive patients.68,74 Since HER2 is relatively uniformly overexpressed in human breast cancers (Fig. 2a), monoclonal antibodies have been developed to the extracellular domain to treat carcinomas overexpressing HER2.
Gene_expression (overexpressing) of carcinomas associated with breast cancer and carcinoma
1) Confidence 0.01 Published 2010 Journal Clinical Medicine Insights. Oncology Section Body Doc Link PMC2883240 Disease Relevance 1.00 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox